| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 Jun 2024 | 6 Jun 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2024 inter alia to consider and approve Intimation of Board Meeting Scheduled on 10th June 2024 in continuation of intimation filed dated 05th June 2024 for Allotment of Equity shares on Preferential Basis against Acquisition of Equity stake in Varenyam Healtcare Pvt & Varenyem Biolifesciences Pvt Ltd. Outcome of Board meeting held on 10th June, 2024 (As Per BSE Announcement Dated on: 10/06/2024) | ||
| Board Meeting | 5 Jun 2024 | 26 May 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2024 inter alia to consider and approve Intimation of Board Meeting as Scheduled on 5th June 2024 Intimation of Allotment of Equity Shares on Preferential Basis (As Per BSE Announcement Dated on:05/06/2024) | ||
| Board Meeting | 22 May 2024 | 10 May 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 inter alia to consider and approve To Consider and approve Audited Financial Resut (Standalone & Consolidated) of the company for Year ended on 31st March 2024 and quarterly result and other matters as may be approved by the chairman of the meeting Intimation of Board Meeting Scheduled on 22nd May, 2024 to consider and recommend Final Dividend for Financial Year ended on 31st March, 2024. (As Per BSE Announcement dated on 11.05.2024) Declaration of Financial Result for Quarter and Financial year ended on 31.03.2024 (As Per BSE Announcement Dated on 22.05.2024) | ||
| Board Meeting | 29 Apr 2024 | 25 Apr 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (d) of SEBI LODR provision for Preferential Allotment of Equity Shares Outcome of Board meeting held 29th April, 2024 (As Per BSE Announcement Dated on 29.04.2024) | ||
| Board Meeting | 13 Feb 2024 | 31 Jan 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Board meeting for Adoption of unaudited Financial Statement for quarter ended on 31.12.2023 Financial Result Q3 (As Per BSE Announcement Dated on 13/02/2024) | ||
| Board Meeting | 9 Nov 2023 | 1 Nov 2023 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve To Consider unaudutied Financial Result & RPT transaction as on 30th September 2023 Board meeting outcome for unaudited Financial result- outcome of the Board Meeting held on 09.11.2023 (As Per BSE Announcement dated on 09.11.2023) | ||
| Board Meeting | 31 Aug 2023 | 31 Aug 2023 |
| Outcome of the Board Meeting of the Company in its meeting held on Today i.e. Thursday, the 31st Day of August, 2023. The company has fixed record 25th September, 2023 for the purpose of determining the members eligible to receive the final dividend for the financial year 2022-23. | ||
| Board Meeting | 9 Aug 2023 | 1 Aug 2023 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve The unaudited financial results of the Company for the Quarter ended on June 30 2023. In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 09th August, 2023, has considered and approved the Unaudited Financial Results for the Quarter ended 30th June, 2023 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. (As Per BSE Announcement Dated on 09.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
